mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.0062 |
0.8 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.8 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0065 |
0.8 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.8 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.0082 |
0.9 |